Ioannis I. Spiliotis

Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Partial restoration of counterregulatory circulating glucagon by dapagliflozin and low-dose glibenclamide in men with type 1 diabetes: in vitro studies and randomised clinical crossover trial.

Partial restoration of counterregulatory circulating glucagon by dapagliflozin and low-dose glibenclamide in men with type 1 diabetes: in vitro studies and randomised clinical crossover trial.

Journal: EBioMedicine
Published: November 07, 2025

Development and validation of a diagnostic prediction model for pancreatic ductal adenocarcinoma: VAPOR 1, protocol for a prospective multicentre case-control study.

Development and validation of a diagnostic prediction model for pancreatic ductal adenocarcinoma: VAPOR 1, protocol for a prospective multicentre case-control study.

Journal: BMJ open
Published: August 27, 2025

Effectiveness of a digital health and financial incentive intervention to promote physical activity in patients with type 2 diabetes: study protocol for a randomised controlled trial with a nested qualitative study-ACTIVATE trial.

Effectiveness of a digital health and financial incentive intervention to promote physical activity in patients with type 2 diabetes: study protocol for a randomised controlled trial with a nested qualitative study-ACTIVATE trial.

Journal: Trials
Published: July 17, 2024

Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma: a retrospective, multicentre, cohort study of 3679 patients with long-term imaging surveillance.

Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma: a retrospective, multicentre, cohort study of 3679 patients with long-term imaging surveillance.

Journal: The lancet. Diabetes & endocrinology
Published: March 08, 2022

Reducing hyperglucagonaemia in type 2 diabetes using low-dose glibenclamide: Results of the LEGEND-A pilot study.

Reducing hyperglucagonaemia in type 2 diabetes using low-dose glibenclamide: Results of the LEGEND-A pilot study.

Journal: Diabetes, obesity & metabolism
Published: January 20, 2022

Loss of ZnT8 function protects against diabetes by enhanced insulin secretion.

Loss of ZnT8 function protects against diabetes by enhanced insulin secretion.

Journal: Nature genetics
Published: October 13, 2018

Does Islet Size Really Influence Graft Function After Clinical Islet Transplantation?

Does Islet Size Really Influence Graft Function After Clinical Islet Transplantation?

Journal: Transplantation
Published: August 01, 2018

Electrophysiological properties of human beta-cell lines EndoC-βH1 and -βH2 conform with human beta-cells.

Electrophysiological properties of human beta-cell lines EndoC-βH1 and -βH2 conform with human beta-cells.

Journal: Scientific reports
Published: June 04, 2018

Insulin inhibits glucagon release by SGLT2-induced stimulation of somatostatin secretion.

Insulin inhibits glucagon release by SGLT2-induced stimulation of somatostatin secretion.

Journal: Nature communications
Published: June 22, 2017

δ-cells and β-cells are electrically coupled and regulate α-cell activity via somatostatin.

δ-cells and β-cells are electrically coupled and regulate α-cell activity via somatostatin.

Journal: The Journal of physiology
Published: May 22, 2017

α-cell glucokinase suppresses glucose-regulated glucagon secretion.

α-cell glucokinase suppresses glucose-regulated glucagon secretion.

Journal: Nature communications
Published: May 12, 2017

Reversible changes in pancreatic islet structure and function produced by elevated blood glucose.

Reversible changes in pancreatic islet structure and function produced by elevated blood glucose.

Journal: Nature communications
Published: April 11, 2014
Showing 1-12 of 12

Last Updated: 09/26/2026